| Product Code: ETC9520522 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Pulmonary Embolism Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Pulmonary Embolism Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Pulmonary Embolism Market - Industry Life Cycle |
3.4 Suriname Pulmonary Embolism Market - Porter's Five Forces |
3.5 Suriname Pulmonary Embolism Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.6 Suriname Pulmonary Embolism Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Suriname Pulmonary Embolism Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Suriname Pulmonary Embolism Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Suriname Pulmonary Embolism Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Pulmonary Embolism Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about pulmonary embolism and its risk factors in Suriname |
4.2.2 Growing prevalence of risk factors such as obesity and sedentary lifestyle leading to an increased incidence of pulmonary embolism |
4.2.3 Advancements in diagnostic technologies and treatment options for pulmonary embolism |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in remote areas of Suriname |
4.3.2 High treatment costs associated with managing pulmonary embolism |
4.3.3 Lack of specialized healthcare professionals trained in pulmonary embolism management in Suriname |
5 Suriname Pulmonary Embolism Market Trends |
6 Suriname Pulmonary Embolism Market, By Types |
6.1 Suriname Pulmonary Embolism Market, By Symptoms |
6.1.1 Overview and Analysis |
6.1.2 Suriname Pulmonary Embolism Market Revenues & Volume, By Symptoms, 2021- 2031F |
6.1.3 Suriname Pulmonary Embolism Market Revenues & Volume, By Shortness of Breath, 2021- 2031F |
6.1.4 Suriname Pulmonary Embolism Market Revenues & Volume, By Chest Pain, 2021- 2031F |
6.1.5 Suriname Pulmonary Embolism Market Revenues & Volume, By Cough, 2021- 2031F |
6.1.6 Suriname Pulmonary Embolism Market Revenues & Volume, By Irregular Heartbeat, 2021- 2031F |
6.1.7 Suriname Pulmonary Embolism Market Revenues & Volume, By Dizziness, 2021- 2031F |
6.1.8 Suriname Pulmonary Embolism Market Revenues & Volume, By Fever, 2021- 2031F |
6.2 Suriname Pulmonary Embolism Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Suriname Pulmonary Embolism Market Revenues & Volume, By Chest X-Ray, 2021- 2031F |
6.2.3 Suriname Pulmonary Embolism Market Revenues & Volume, By ECG, 2021- 2031F |
6.2.4 Suriname Pulmonary Embolism Market Revenues & Volume, By MRI, 2021- 2031F |
6.2.5 Suriname Pulmonary Embolism Market Revenues & Volume, By CT Scan, 2021- 2031F |
6.2.6 Suriname Pulmonary Embolism Market Revenues & Volume, By Pulmonary Angiography, 2021- 2031F |
6.2.7 Suriname Pulmonary Embolism Market Revenues & Volume, By Venography, 2021- 2031F |
6.2.8 Suriname Pulmonary Embolism Market Revenues & Volume, By D-Dimer Test, 2021- 2031F |
6.2.9 Suriname Pulmonary Embolism Market Revenues & Volume, By D-Dimer Test, 2021- 2031F |
6.3 Suriname Pulmonary Embolism Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Suriname Pulmonary Embolism Market Revenues & Volume, By Medications, 2021- 2031F |
6.3.3 Suriname Pulmonary Embolism Market Revenues & Volume, By Mechanical Devices, 2021- 2031F |
6.3.4 Suriname Pulmonary Embolism Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4 Suriname Pulmonary Embolism Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Suriname Pulmonary Embolism Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Suriname Pulmonary Embolism Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Suriname Pulmonary Embolism Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5 Suriname Pulmonary Embolism Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Suriname Pulmonary Embolism Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Suriname Pulmonary Embolism Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Suriname Pulmonary Embolism Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Suriname Pulmonary Embolism Market Import-Export Trade Statistics |
7.1 Suriname Pulmonary Embolism Market Export to Major Countries |
7.2 Suriname Pulmonary Embolism Market Imports from Major Countries |
8 Suriname Pulmonary Embolism Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for pulmonary embolism patients in Suriname |
8.2 Number of healthcare facilities offering specialized pulmonary embolism diagnostic and treatment services in Suriname |
8.3 Percentage of pulmonary embolism patients receiving timely and appropriate treatment in Suriname |
8.4 Patient satisfaction scores related to the quality of care received for pulmonary embolism in Suriname |
8.5 Rate of adherence to pulmonary embolism treatment guidelines by healthcare providers in Suriname |
9 Suriname Pulmonary Embolism Market - Opportunity Assessment |
9.1 Suriname Pulmonary Embolism Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.2 Suriname Pulmonary Embolism Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Suriname Pulmonary Embolism Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Suriname Pulmonary Embolism Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Suriname Pulmonary Embolism Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Pulmonary Embolism Market - Competitive Landscape |
10.1 Suriname Pulmonary Embolism Market Revenue Share, By Companies, 2024 |
10.2 Suriname Pulmonary Embolism Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here